On January 19, a broken pipe dumped more than 200 million gallons of raw sewage into the Potomac.
The oral, whole-cell vaccine for enterotoxigenic Escherichia coli was safe and induced protective efficacy in young children in Gambia.
A US surveillance study found a higher incidence rate of invasive E coli than expected, and worrisome levels of antibiotic resistance.
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
The researchers also discovered that UTIs in patients from high-poverty neighborhoods were 60% more likely to be caused by animal-to-human strains.
Molecular analysis and epidemiologic detective work helped uncover a hidden One Health connection between human and animal clusters of multidrug-resistant bacterial infections.
The CDC's FoodNet program has reduced required surveillance from 8 foodborne pathogens to 2, a move some experts warn could leave the country more vulnerable to outbreaks.
The money will enable biotech company Phiogen to advance its bacteriophage-based treatment and preventive for extraintestinal pathogenic E coli infections.
Swiss biotech start-up Baxiva AG will receive $3 million to develop a multivalent glycoconjugate vaccine that targets invasive extraintestinal pathogenic E coli infections.
IDSA emphasized that the VICP be funded appropriately to compensate injured individuals without putting an infeasible burden on vaccine manufacturers that could severely jeopardize vaccine access.
